Want to join the conversation?
$A said its Diagnostic and Genomics Group (DGG) delivered 5% core growth in 2Q16 against a difficult compare. The pathology business continues on its steady trajectory back to market growth rates, highlighted by a strong demand for a new PD-L1 companion and complementary diagnostics test. DGG's operating margin was flat versus a year ago at 15%.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!